David A. Savitz

Last updated

David A. Savitz is a professor of Community Health in the Epidemiology Section of the Program in Public Health, Vice President for Research, and Professor of Obstetrics and Gynecology, at The Alpert Medical School of Brown University, and Associate Director for Perinatal Research in The Department of Obstetrics and Gynecology at Women & Infants Hospital, both in Providence, Rhode Island. [1] [2] Savitz is the author of Interpreting epidemiologic evidence: strategies for study design and analysis ( ISBN   0-19-510840-X) and more than 275 peer-reviewed articles. He was elected to the Institute of Medicine in 2007. [3]

Contents

Biography

Savitz graduated from Brandeis University with a B.A. degree in psychology in 1975. He completed his M.S. degree in preventive medicine at Ohio State University in 1978, and earned his Ph.D. degree in epidemiology from the University of Pittsburgh Graduate School of Public Health in 1982. [4]

Until 1985, Savitz was Assistant Professor in the Department of Preventive Medicine and Biometrics at the University of Colorado School of Medicine. He then moved to the University of North Carolina; he was appointed Professor and Chair of the University's Department of Epidemiology in 1996, a position he held until 2005.

In January 2006, he joined The Mount Sinai Medical Center as Professor of Preventive Medicine and Director of the Epidemiology, Biostatistics, and Prevention Institute.

Savitz is a former editor at the American Journal of Epidemiology and a member of the Epidemiology and Disease Control - 1 Study Section of the National Institutes of Health. [5] He is a former president of the Society for Epidemiologic Research and the Society for Pediatric and Perinatal Epidemiologic Research and the North American Regional Councilor for the International Epidemiological Association. [6] He is currently an editor at the journal Epidemiology.[ citation needed ]

Interests include a range of epidemiological, pre- and postnatal and cancer issues, including the connection between miscarriage and C8/C8S, [7] links between alcohol consumption and breast cancer, [8] the effect of drinking water DBPs on fetal survival, [9] links between caffeine and miscarriage [10] and exposure to chemicals and the risk of breast cancer. [11]

In September 2010, Savitz joined Brown University's Alpert Medical School as Professor of Community Health (Epidemiology Section) and Obstetrics and Gynecology. In addition, he joined The Department of Obstetrics and Gynecology at Women & Infants Hospital of Rhode Island as associate director of the Division of Research.

Active grants

Savitz’s research interests include a range of topics in perinatal and pediatric health, cancer, and the environment. These include environmental influences on miscarriage, caffeine and pregnancy outcome, and environmental influences on cancer in children and adults. He has completed 47 grants and is principal investigator or investigator on the following active grants:

SourceTitle
Garden City Group, Inc.Analyses of C8 Health Project Data on Reproductive Outcomes [12]
Garden City Group, Inc.C8 Exposure and birth Outcomes based on Vital Records [12]
NIH R21HD0588111The Epidemiology of Hospitalized Postpartum Depression
NIH 1R01HD058008Prenatal Smoking, Maternal & Fetal Genetic Variation & Risk of Preeclampsia
U01-DE017018Risk Factors for Onset and Persistence of TMD
HHSN26720070047CNational Children’s Study Vanguard Centers
Garden City Group, Inc.C8 Exposure and Neurobehavioral Development Study
1R01HL086507Cardiovascular Health of Seniors and the Built Environment

Books

Publications

Partial list:

Related Research Articles

<span class="mw-page-title-main">Miscarriage</span> Natural death and expulsion of an embryo or fetus before its independent survival

Miscarriage, also known in medical terms as a spontaneous abortion, is the death and expulsion of an embryo or fetus before it can survive independently. The term miscarriage is sometimes used to refer to all forms of pregnancy loss and pregnancy with abortive outcomes before 20 weeks of gestation.

Morning sickness, also called nausea and vomiting of pregnancy (NVP), is a symptom of pregnancy that involves nausea or vomiting. Despite the name, nausea or vomiting can occur at any time during the day. Typically the symptoms occur between the 4th and 16th week of pregnancy. About 10% of women still have symptoms after the 20th week of pregnancy. A severe form of the condition is known as hyperemesis gravidarum and results in weight loss.

<span class="mw-page-title-main">Placenta praevia</span> Medical condition

Placenta praevia is when the placenta attaches inside the uterus but in a position near or over the cervical opening. Symptoms include vaginal bleeding in the second half of pregnancy. The bleeding is bright red and tends not to be associated with pain. Complications may include placenta accreta, dangerously low blood pressure, or bleeding after delivery. Complications for the baby may include fetal growth restriction.

Recurrent miscarriage or recurrent pregnancy loss (RPL) is the spontaneous loss of 2-3 pregnancies that is estimated to affect up to 5% of women. The exact number of pregnancy losses and gestational weeks used to define RPL differs among medical societies. In the majority of cases, the exact cause of pregnancy loss is unexplained despite genetic testing and a thorough evaluation. When a cause for RPL is identified, almost half are attributed to a chromosomal abnormality. RPL has been associated with several risk factors including parental and genetic factors, congenital and acquired anatomical conditions, lifestyle factors, endocrine disorders, thrombophila, immunological factors, and infections. The American Society of Reproductive Medicine recommends a thorough evaluation after 2 consecutive pregnancy losses, however, this can differ from recommendations by other medical societies. RPL evaluation be evaluated by numerous tests and imaging studies depending on the risk factors. These range from cytogenetic studies, blood tests for clotting disorders, hormone levels, diabetes screening, thyroid function tests, sperm analysis, antibody testing, and imaging studies. Treatment is typically tailored to the relevant risk factors and test findings. RPL can have a significant impact on the psychological well-being of couples and has been associated with higher levels of depression, anxiety, and stress. Therefore, it is recommended that appropriate screening and management be considered by medical providers.  

<span class="mw-page-title-main">Gestational trophoblastic disease</span> Pregnancy-related tumours

Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumours. These tumours are rare, and they appear when cells in the womb start to proliferate uncontrollably. The cells that form gestational trophoblastic tumours are called trophoblasts and come from tissue that grows to form the placenta during pregnancy.

The abortion–breast cancer hypothesis posits that having an induced abortion can increase the risk of getting breast cancer. This hypothesis is at odds with mainstream scientific opinion and is rejected by major medical professional organizations; despite this, it continues to be widely propagated as pseudoscience, typically in service of an anti-abortion agenda.

In obstetrics, gestational age is a measure of the age of a pregnancy taken from the beginning of the woman's last menstrual period (LMP), or the corresponding age of the gestation as estimated by a more accurate method, if available. Such methods include adding 14 days to a known duration since fertilization, or by obstetric ultrasonography. The popularity of using this measure of pregnancy is largely due to convenience: menstruation is usually noticed, while there is generally no convenient way to discern when fertilization or implantation occurred.

<span class="mw-page-title-main">Pregnancy</span> Time of offspring development in mothers body

Pregnancy is the time during which one or more offspring develops (gestates) inside a woman's uterus (womb). A multiple pregnancy involves more than one offspring, such as with twins.

<span class="mw-page-title-main">Cervical cerclage</span> Obstetrics medical procedure

Cervical cerclage, also known as a cervical stitch, is a treatment for cervical weakness, when the cervix starts to shorten and open too early during a pregnancy causing either a late miscarriage or preterm birth. In women with a prior spontaneous preterm birth and who are pregnant with one baby, and have shortening of the cervical length less than 25 mm, a cerclage prevents a preterm birth and reduces death and illness in the baby.

Molecular epidemiology is a branch of epidemiology and medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations. This field has emerged from the integration of molecular biology into traditional epidemiological research. Molecular epidemiology improves our understanding of the pathogenesis of disease by identifying specific pathways, molecules and genes that influence the risk of developing disease. More broadly, it seeks to establish understanding of how the interactions between genetic traits and environmental exposures result in disease.

The Canadian Perinatal Network (CPN) is made up of Canadian researchers who collaborate on research issues relating to perinatal care. The network commenced in September 2005, and includes members from 25 tertiary perinatal units. CPN will enable health care professionals, researchers, and administrators to participate actively in clinical, epidemiologic, health services, health policy, and informatics research aimed at improving the effectiveness and efficiency of perinatal care.

Irva Hertz-Picciotto, is an environmental epidemiologist best known for her studies of autism. She is Professor and Chief of the Division of Environmental and Occupational Health in the Department of Public Health Sciences, at the University of California, Davis (UC-Davis). In addition, she is on the Research Faculty of the MIND Institute at UC-Davis; the Deputy Director of the UC-Davis Center for Children's Environmental Health; and on the faculty of the Center for Occupational and Environmental Health of the Universities of California at Berkeley, Davis, and San Francisco. Hertz-Picciotto serves on the advisory board of the anti-toxic chemical NGO Healthy Child, Healthy World.

Nebojsa V. Radunovic is a university professor of obstetrics and gynecology at University of Belgrade's School of Medicine* Reference 1, Chair of Human reproduction department at Institute for Obstetrics and Gynecology, Clinical Center of Serbia and a corresponding member of the Serbian Academy of Sciences and Arts. He was born in 1954 in Kosovska Mitrovica, Kosovo, then SFRY.

Michael L. Brodman is an American gynecologist and obstetrician and currently the Ellen and Howard C. Katz Professor and Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai Hospital, Mount Sinai Health System, and Icahn School of Medicine at Mount Sinai in New York City. He is recognized internationally as a pioneer in the field of urogynecology.

<span class="mw-page-title-main">High-risk pregnancy</span> Medical condition

A high-risk pregnancy is a pregnancy where the mother or the fetus has an increased risk of adverse outcomes compared to uncomplicated pregnancies. No concrete guidelines currently exist for distinguishing “high-risk” pregnancies from “low-risk” pregnancies; however, there are certain studied conditions that have been shown to put the mother or fetus at a higher risk of poor outcomes. These conditions can be classified into three main categories: health problems in the mother that occur before she becomes pregnant, health problems in the mother that occur during pregnancy, and certain health conditions with the fetus.

A pre-existing disease in pregnancy is a disease that is not directly caused by the pregnancy, in contrast to various complications of pregnancy, but which may become worse or be a potential risk to the pregnancy. A major component of this risk can result from necessary use of drugs in pregnancy to manage the disease.

Early pregnancy bleeding is vaginal bleeding before 14 weeks of gestational age. If the bleeding is significant, hemorrhagic shock may occur. Concern for shock is increased in those who have loss of consciousness, chest pain, shortness of breath, or shoulder pain.

<span class="mw-page-title-main">Michael B. Bracken</span> Perinatal epidemiologist

Michael B. Bracken is an American perinatal epidemiologist. He is the Susan Dwight Bliss Professor of Epidemiology at the Yale School of Public Health, and Professor of Obstetrics, Gynecology and Reproductive Sciences, and Professor of Neurology at the Yale School of Medicine. He is co-director of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology.

Miscarriage risks are those circumstances, conditions, and substances that increase the risk of miscarriage. Some risks are modifiable and can be changed. Other risks cannot be modified and can't be changed. Risks can be firmly tied to miscarriages and others are still under investigation. In addition, there are those circumstances and treatments that have not been found effective in preventing miscarriage. When a woman keeps having miscarriages, infertility is present.

Jennifer R. Niebyl (1942) is a Canadian obstetrics and gynecology researcher and professor. She has made significant contributions to the understanding of drugs in pregnancy and lactation.

References

  1. Research Profile at Brown University
  2. Flaherty, Colleen (25 April 2014). "In Her Own Words". Inside Higher Ed. Retrieved 10 May 2015.
  3. "Institute of Medicine of the National Academies". Archived from the original on 2010-02-09. Retrieved 2009-12-29.
  4. Curriculum Vitae David A. Savitz, Ph.D. - website of the Carolina Population Center
  5. C8 Science Panel – Members
  6. "American Association for the Advancement of Science". Archived from the original on 2010-04-28. Retrieved 2009-12-29.
  7. Dave Payne, Sr. (March 27, 2009). "Science Panel: No link between C8, miscarriages". News and Sentinel. Retrieved December 29, 2009.
  8. "Alcohol consumption and breast cancer". ABC News. February 24, 2009. Retrieved December 29, 2009.
  9. North Carolina Center for Reproductive Medicine
  10. Barbara Feder Ostrov (January 21, 2008). "Large amounts of caffeine may increase miscarriage risk, study finds". The Monitor. Retrieved December 29, 2009.
  11. Norma Peterson (June 1996). "Havoc in Our Hormones". Breast Cancer Action. Retrieved December 29, 2009.
  12. 1 2 Ken Ward, Jr (March 26, 2009). "C8 exposure linked to birth defects, preeclampsia". The Charleston Gazette. Retrieved December 29, 2009.